Page last updated: 2024-11-04

terbutaline and Pulmonary Alveolar Proteinosis

terbutaline has been researched along with Pulmonary Alveolar Proteinosis in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.

Research Excerpts

ExcerptRelevanceReference
"Terbutaline has been shown to accelerate the rate of alveolar fluid clearance and augment surfactant secretion."1.37Therapeutic role of terbutaline in a rat whole-lung lavage model. ( Bai, C; Chen, Z; Jiang, J; Li, S; Song, Y; Wang, X; Wu, X, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, X1
Li, S1
Wang, X1
Song, Y1
Chen, Z1
Jiang, J1
Bai, C1

Other Studies

1 other study available for terbutaline and Pulmonary Alveolar Proteinosis

ArticleYear
Therapeutic role of terbutaline in a rat whole-lung lavage model.
    Experimental lung research, 2011, Volume: 37, Issue:9

    Topics: Animals; Blood Gas Analysis; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Bronchodilator Ag

2011